Which has grown faster, ASND or BAX?

Over the past five years, ASND grew revenue faster — ASND at a 189.92% CAGR versus BAX at -1.22%.

Does ASND or BAX pay a bigger dividend?

BAX pays a dividend (0.17% yield), while ASND has no payments in the available dividend history.

Is ASND or BAX more profitable?

ASND runs the higher net margin — ASND at 71.08% versus BAX at -9.27%.

How have ASND and BAX total returns compared?

Over the past 10 years, ASND delivered 27.41% and BAX delivered -5.15% annualized total return. Past performance doesn't predict future results.

Ascendis Pharma A/S (ASND) vs Baxter International Inc. (BAX)

A side-by-side comparison of Ascendis Pharma A/S and Baxter International Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ASND

Ascendis Pharma A/S

$14.16B

$228.03HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

BAX

Baxter International Inc.

$12.52B

$24.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ASND vs BAX

growth of $100 · dividends reinvested · last 10y

ASND +1027.2% (+27.4%/yr)BAX -39.8% (-4.9%/yr)ASND compounded faster over this window

Log scale — wide-divergence pair

ASND BAX

ASND vs BAX: by the numbers

•ASND is the larger company ($14.16B vs $12.52B market cap).
•ASND is profitable (71.08% net margin) while BAX runs a net loss (-9.27%).
•ASND grew revenue faster over the past five years (189.92% vs -1.22% CAGR).
•BAX pays a dividend (0.17% yield), while ASND has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ASND	BAX
P/E ratio	17.33	N/A
Forward P/E	N/A	11.79
P/S ratio	11.59	1.09
P/B ratio	8.64	2.02
EV / EBITDA	93.79	29.51
FCF yield	2.73%	5.41%

Profitability

Metric	ASND	BAX
Gross margin	90.18%	30.08%
Operating margin	-18.92%	-2.39%
Net margin	71.08%	-9.27%
ROE	52.97%	-17.13%
ROIC	5.85%	-1.61%

Dividends

Metric	ASND	BAX
Dividend yield	N/A	0.17%

Growth (annualized)

Metric	ASND	BAX
Revenue CAGR (5Y)	189.92%	-1.22%
FCF CAGR (5Y)	N/A	-12.92%
Total return CAGR (5Y)	7.40%	-19.87%

Frequently asked

Which has grown faster, ASND or BAX?: Over the past five years, ASND grew revenue faster — ASND at a 189.92% CAGR versus BAX at -1.22%.
Does ASND or BAX pay a bigger dividend?: BAX pays a dividend (0.17% yield), while ASND has no payments in the available dividend history.
Is ASND or BAX more profitable?: ASND runs the higher net margin — ASND at 71.08% versus BAX at -9.27%.
How have ASND and BAX total returns compared?: Over the past 10 years, ASND delivered 27.41% and BAX delivered -5.15% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ASND analysis Full BAX analysis Interactive comparison tool

Dig into the metrics

Ascendis Pharma A/S P/E ratio Baxter International dividend yield Ascendis Pharma A/S ROE Baxter International ROE Ascendis Pharma A/S operating margin Baxter International operating margin Ascendis Pharma A/S revenue growth Baxter International revenue growth Ascendis Pharma A/S free cash flow Baxter International free cash flow

Ascendis Pharma A/S & Baxter International appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.